SC 13G/A: COLLEGIUM PHARMACEUTICAL, INC
Ticker: COLL · Form: SC 13G/A · Filed: Nov 13, 2024 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | SC 13G/A |
| Filed Date | Nov 13, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by COLLEGIUM PHARMACEUTICAL, INC.
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G/A filing submitted by Collegium Pharmaceutical, Inc (ticker: COLL) to the SEC on Nov 13, 2024.
What is the risk level of this SC 13G/A filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of).
How long is this filing?
Collegium Pharmaceutical, Inc's SC 13G/A filing is 4 pages with approximately 1,270 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,270 words · 5 min read · ~4 pages · Grade level 10.9 · Accepted 2024-11-13 16:30:24
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of
Filing Documents
- tm2427812d6_sc13ga.htm (SC 13G/A) — 66KB
- 0001104659-24-117743.txt ( ) — 68KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. DATED: November 13, 2024 RUBRIC CAPITAL MANAGEMENT LP By: /s/ Michael Nachmani Name: Michael Nachmani Title: Chief Operating Officer /s/ David Rosen DAVID ROSEN